126 related articles for article (PubMed ID: 32604116)
1. Non-Hodgkin Lymphoma With an Atypical Presentation: A Solitary Paravertebral Mass on FDG PET/CT.
Shen G; Kuang A
Clin Nucl Med; 2020 Nov; 45(11):876-877. PubMed ID: 32604116
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
Zhang Q; Tian T; Wang L; Qiu H; Li D
Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
[TBL] [Abstract][Full Text] [Related]
3. A Case of Solitary Laryngotracheal Lymphoma Evaluated by 18F-FDG PET/CT.
Wang Q; Tang W; Yang S; Chen Y
Clin Nucl Med; 2021 Aug; 46(8):686-687. PubMed ID: 33782279
[TBL] [Abstract][Full Text] [Related]
4. Value of
Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
[TBL] [Abstract][Full Text] [Related]
5. Solitary Vulvar Involvement of Ovarian Non-Hodgkin Lymphoma Mimicking Bartholin's Abscess on 18F-FDG PET/CT.
Beyhan E; Ergül N; Bektaş S; Erol Ö; Çermik TF
Clin Nucl Med; 2021 Mar; 46(3):255-257. PubMed ID: 33351504
[TBL] [Abstract][Full Text] [Related]
6. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
7. Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm.
Radhakrishnan RK; Mittal BR; Basher RK; Prakash G; Malhotra P; Kalra N; Das A
Nucl Med Commun; 2018 Jan; 39(1):74-82. PubMed ID: 29189443
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT Imaging of Primary Gastric Lymphoma.
Davis BS; Thompson TA; Wolin EA
J Nucl Med Technol; 2016 Dec; 44(4):263-264. PubMed ID: 27493260
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment.
Fujii H; Tanaka H; Nomoto Y; Harata N; Oota S; Isogai J; Yoshida K
Medicine (Baltimore); 2018 Apr; 97(17):e0543. PubMed ID: 29703034
[TBL] [Abstract][Full Text] [Related]
10. A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology.
Fukunaga H; Tatewaki Y; Mutoh T; Shimomura H; Yamamoto S; Terao C; Totsune T; Nakagawa M; Taki Y
Am J Case Rep; 2018 Mar; 19():292-295. PubMed ID: 29535291
[TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
12. Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT.
Hod N; Lantsberg S; Anconina R; Levin D; Nalbandyan K; Levi I
Clin Nucl Med; 2019 Jun; 44(6):e409-e412. PubMed ID: 30985428
[TBL] [Abstract][Full Text] [Related]
13. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
Chen S; Wang S; He K; Ma C; Fu H; Wang H
Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
[TBL] [Abstract][Full Text] [Related]
14. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma.
Chang CC; Cho SF; Chen YW; Tu HP; Lin CY; Chang CS
Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526
[TBL] [Abstract][Full Text] [Related]
15. Primary spinal epidural non-Hodgkin lymphoma demonstrated by FDG PET/CT.
Ho L; Valenzuela D; Negahban A; Wassef H
Clin Nucl Med; 2010 Jul; 35(7):487-9. PubMed ID: 20548138
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
Badr S; Kotb M; Elahmadawy MA; Moustafa H
Clin Nucl Med; 2018 Dec; 43(12):e428-e438. PubMed ID: 30358625
[TBL] [Abstract][Full Text] [Related]
17. Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma.
Xiao-Xue W; Xinyue H; Lijun Z
Med Clin (Barc); 2020 Jan; 154(2):61-65. PubMed ID: 31757394
[TBL] [Abstract][Full Text] [Related]
18. Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer.
Ahmadzadehfar H; Sabet A; Näke K; Hinterthaner B; Biersack HJ; Ezziddin S
Clin Nucl Med; 2009 Mar; 34(3):168-70. PubMed ID: 19352282
[TBL] [Abstract][Full Text] [Related]
19. 64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.
Lee I; Lim I; Lee KC; Kang HJ; Lim SM
Clin Nucl Med; 2023 Feb; 48(2):e82-e83. PubMed ID: 36127796
[TBL] [Abstract][Full Text] [Related]
20.
Li GN; Xiao L; Li L
Hell J Nucl Med; 2020; 23(3):356-357. PubMed ID: 33306766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
